Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors
Clinical trial NCT01824875 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01824875
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-08
- Primary completion
- 2021-05-26
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.